All lobbying filings

2359 Strategies

2359 Strategies filed a Q1 report for Travere Therapeutics on April 19, 2025, reporting $12,000 in lobbying income.

Lobbying for Travere Therapeutics · Biopharmaceutical company

As filed: 2359 STRATEGIES for TRAVERE THERAPEUTICS.

All filings by 2359 Strategies · Everything Travere Therapeutics has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 19, 2025

Income

$12,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 1

CHARLES DUJON

Previously held: Legislative Director (1998-2013), Rep. Jesse Jackson, Jr.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 5

Medicare/Medicaid